Kevin W. Yau

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications

Obesity management for kidney TRANSPLANTation: protocol for the vanguard phase of an innovative randomised controlled trial, embedded in routine care (OK-TRANSPLANT 2).

Obesity management for kidney TRANSPLANTation: protocol for the vanguard phase of an innovative randomised controlled trial, embedded in routine care (OK-TRANSPLANT 2).

Journal: BMJ open
Published: August 11, 2026

Targeting Interleukin-6 for Treatment of CKD and Cardiovascular Disease.

Targeting Interleukin-6 for Treatment of CKD and Cardiovascular Disease.

Journal: Kidney international reports
Published: April 21, 2026

Application of artificial intelligence in the Hong Kong Medical Licensing Examination.

Application of artificial intelligence in the Hong Kong Medical Licensing Examination.

Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: April 09, 2026

Provider perspectives of clinical decision support for chronic kidney disease management: a cross-sectional study.

Provider perspectives of clinical decision support for chronic kidney disease management: a cross-sectional study.

Journal: BMC medical informatics and decision making
Published: March 11, 2026

The Oxford Classification Should Remain the Gold Standard for Classification of IgA Nephropathy: PRO.

The Oxford Classification Should Remain the Gold Standard for Classification of IgA Nephropathy: PRO.

Journal: Kidney360
Published: September 05, 2025

Biomarkers for cardiovascular-kidney metabolic syndrome: Clinical utility in diagnosis, screening, and treatment.

Biomarkers for cardiovascular-kidney metabolic syndrome: Clinical utility in diagnosis, screening, and treatment.

Journal: Diabetes, obesity & metabolism
Published: July 30, 2025

SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS Inhibitors.

SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS Inhibitors.

Journal: JAMA internal medicine
Published: April 28, 2025

Long-Term Outcomes of COVID-19 in Patients Receiving Maintenance Dialysis: A Propensity Score Matched Population-Based Cohort Study.

Long-Term Outcomes of COVID-19 in Patients Receiving Maintenance Dialysis: A Propensity Score Matched Population-Based Cohort Study.

Journal: Kidney360
Published: March 11, 2025

Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond.

Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond.

Journal: Current opinion in nephrology and hypertension
Published: March 06, 2025

How should we measure and interpret glomerular inflammation and what is the best anti-inflammatory approach in IgA nephropathy?

How should we measure and interpret glomerular inflammation and what is the best anti-inflammatory approach in IgA nephropathy?

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: February 07, 2025

Glucagon-like Peptide-1 Receptor Agonists and Risk of Major Adverse Cardiovascular Events in Patients With CKD.

Glucagon-like Peptide-1 Receptor Agonists and Risk of Major Adverse Cardiovascular Events in Patients With CKD.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: February 07, 2025

Interventions to improve cognitive performance in chronic kidney disease: A scoping review.

Interventions to improve cognitive performance in chronic kidney disease: A scoping review.

Journal: PloS one
Published: December 20, 2024
Showing 1-12 of 52

Last Updated: 09/26/2026